{"nct_id":"NCT03960541","title":"Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003)","status":"TERMINATED","status_verified_date":"2023-01","start_date":"2020-08-31","start_date_type":"ACTUAL","primary_completion_date":"2021-05-27","primary_completion_date_type":"ACTUAL","completion_date":"2021-05-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}